v3.25.2
SUPPLEMENTAL FINANCIAL INFORMATION
6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SUPPLEMENTAL FINANCIAL INFORMATION SUPPLEMENTAL FINANCIAL INFORMATION
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.
As of
June 30, 2025December 31, 2024
Cash and cash equivalents(1)
$3,737 $2,874 
Short-term restricted cash26 16 
Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position
3,763 2,889 
Long-term restricted cash(2)
Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows
$3,766 $2,893 
(1) The increase in Cash and cash equivalents was primarily due to proceeds from the issuance of senior unsecured notes by the Company in the second quarter of 2025. Refer to Note 8, “Borrowings” for further information.
(2) Long-term restricted cash is recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.

INVENTORIES.
As of
June 30, 2025December 31, 2024
Raw materials$1,026 $921 
Work in process93 92 
Finished goods1,164 926 
Inventories
$2,283 $1,939 
Certain inventory items are long-term in nature and therefore have been recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position and are not reflected in the table above. See the supplemental table “All Other Non-Current Assets” for further information.

PROPERTY, PLANT, AND EQUIPMENT – NET.
As of
June 30, 2025December 31, 2024
Land and improvements
$152 $66 
Buildings, structures, and related equipment
2,199 1,943 
Machinery and equipment
2,975 2,705 
Leasehold improvements and manufacturing plants under construction
516 553 
Total property, plant, and equipment, at original cost
5,841 5,267 
Accumulated depreciation
(3,266)(3,080)
Right-of-use operating lease assets, net of amortization
386 364 
Property, plant, and equipment – net
$2,962 $2,550 

ALL OTHER ASSETS AND ALL OTHER LIABILITIES.

All Other Current Assets
As of
June 30, 2025December 31, 2024
Prepaid expenses and deferred costs
$237 $188 
Financing receivables – net
100 90 
Derivative instruments(1)
115 123 
Tax receivables
144 115 
Other(2)
42 16 
All other current assets
$638 $532 
(1) Derivative instruments include the related accrued interest. Refer to Note 12, “Financial Instruments and Fair Value Measurements” for further information.
(2) As of June 30, 2025, Other primarily consists of indemnity assets associated with separation agreements with GE. These amounts were not material as of December 31, 2024.

All Other Non-Current Assets
As of
June 30, 2025December 31, 2024
Prepaid pension asset
$775 $657 
Equity method and other investments
244 373 
Financing receivables – net
190 183 
Long-term receivables – net
191 142 
Inventories
145 139 
Contract and other deferred assets
207 208 
Capitalized cloud computing arrangement implementation costs143 84 
Other(1)
180 164 
All other non-current assets
$2,076 $1,950 
(1) Other primarily consists of indemnity assets associated with separation agreements with GE, derivative instruments, and tax receivables.
All Other Current Liabilities
As of
June 30, 2025December 31, 2024
Sales allowances and related liabilities
$228 $242 
Income and indirect tax liabilities including uncertain tax positions
181 279 
Product warranties
166 168 
Accrued logistics and utilities
177 163 
Operating lease liabilities
127 115 
Derivative instruments(1)
79 90 
Interest payable on borrowings
89 92 
Environmental and asset retirement obligations
14 17 
Other(2)
363 386 
All other current liabilities
$1,426 $1,552 
(1) Derivative instruments include the related accrued interest. Refer to Note 12, “Financial Instruments and Fair Value Measurements” for further information.
(2) Other primarily consists of miscellaneous accrued costs and contingent consideration liabilities.

All Other Non-Current Liabilities
As of
June 30, 2025December 31, 2024
Contract liabilities
$741 $686 
Operating lease liabilities271 270 
Environmental and asset retirement obligations407 291 
Income and indirect tax liabilities including uncertain tax positions
170 237 
Derivative instruments(1)
154 64 
Finance lease obligations
43 40 
Sales allowances and related liabilities
27 23 
Other(2)
192 184 
All other non-current liabilities
$2,005 $1,796 
(1) Derivative instruments include the related accrued interest. Refer to Note 12, “Financial Instruments and Fair Value Measurements” for further information.
(2) Other primarily consists of miscellaneous accrued costs, indemnity liabilities associated with separation agreements with GE, and contingent consideration liabilities.

SUPPLY CHAIN FINANCE PROGRAMS.

The Company participates in voluntary supply chain finance programs which provide participating suppliers the opportunity to sell their GE HealthCare receivables to third parties at the sole discretion of both the suppliers and the third parties. We evaluate supply chain finance programs to ensure the use of a third-party intermediary to settle our trade payables does not change the nature, existence, amount, or timing of our trade payables and does not provide the Company with any direct economic benefit. If any characteristics of the trade payables change or we receive a direct economic benefit, we reclassify the trade payables to borrowings. In connection with the supply chain finance programs, payment terms normally range from 30 to 180 days, depending on the underlying supplier agreements.

Included within Accounts payable in the Condensed Consolidated Statements of Financial Position as of June 30, 2025 and December 31, 2024 were $346 million and $394 million, respectively, of confirmed supplier invoices that are outstanding and subject to third-party programs.

REDEEMABLE NONCONTROLLING INTERESTS.

The Company has noncontrolling interests with redemption features. These redemption features, such as put options, could require the Company to purchase the noncontrolling interests upon the occurrence of certain events. All noncontrolling interests with redemption features that are not solely within our control are recognized within the Condensed Consolidated Statements of Financial Position between liabilities and equity. Redeemable noncontrolling interests are initially recorded at the issuance date fair value. Those that are currently redeemable, or probable of becoming redeemable, are subsequently adjusted to the greater of current redemption value or initial carrying value.
Activity attributable to redeemable noncontrolling interests is presented below.
For the six months ended June 30
20252024
Balance at beginning of period$188 $165 
Net income attributable to redeemable noncontrolling interests
37 16 
Distributions to redeemable noncontrolling interests and other
(5)(4)
Balance at end of period $220 $177 

OTHER INCOME (EXPENSE) NET.
For the three months ended June 30
For the six months ended June 30
2025202420252024
Net financing income and investment income (loss)
$$— $$(15)
Equity method income (loss)
Change in fair value of assumed obligations
(10)(9)(18)(17)
Gain on remeasurement of NMP equity method investment(1)
— — 97 — 
Other items, net(2)
11 21 
Total other income (expense) – net
$(1)$1 $98 $(8)
(1) Refer to Note 7, “Acquisitions, Goodwill, and Other Intangible Assets” for additional information on the NMP acquisition.
(2) Other items, net primarily consists of a mix of licensing and royalty income, lease income, change in tax indemnities, and gains and losses related to derivatives. Additionally, for the six months ended June 30, 2025 it includes a realization of a gain contingency recorded in the first quarter of 2025.